AAAAAA

   
Results: 1-25 | 26-50 | 51-63
Results: 1-25/63
HUMANIZED M195 MONOCLONAL-ANTIBODY CONJUGATED TO RECOMBINANT GELONIN - AN ANTI-CD33 IMMUNOTOXIN WITH ANTILEUKEMIC ACTIVITY
Authors: PAGLIARO LC LIU BS MUNKER R ANDREEFF M FREIREICH EJ SCHEINBERG DA ROSENBLUM MG
Citation: Lc. Pagliaro et al., HUMANIZED M195 MONOCLONAL-ANTIBODY CONJUGATED TO RECOMBINANT GELONIN - AN ANTI-CD33 IMMUNOTOXIN WITH ANTILEUKEMIC ACTIVITY, Clinical cancer research, 4(8), 1998, pp. 1971-1976
4 DECADES OF THERAPY FOR AML
Authors: FREIREICH EJ
Citation: Ej. Freireich, 4 DECADES OF THERAPY FOR AML, Leukemia, 12, 1998, pp. 54-56
SUPPRESSION OF CYTOGENETIC CLONAL EVOLUTION WITH INTERFERON-ALPHA THERAPY IN PATIENTS WITH PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
Authors: CORTES J TALPAZ M OBRIEN S RIOS MB MAJLIS A KEATING M FREIREICH EJ KANTARJIAN H
Citation: J. Cortes et al., SUPPRESSION OF CYTOGENETIC CLONAL EVOLUTION WITH INTERFERON-ALPHA THERAPY IN PATIENTS WITH PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 16(10), 1998, pp. 3279-3285
EVALUATION AND COMPARISON OF 3 MOBILIZATION METHODS FOR THE COLLECTION OF GRANULOCYTES
Authors: JENDIROBA DB LICHTIGER B ANAISSIE E REDDY V OBRIEN S KANTARJIAN H FREIREICH EJ
Citation: Db. Jendiroba et al., EVALUATION AND COMPARISON OF 3 MOBILIZATION METHODS FOR THE COLLECTION OF GRANULOCYTES, Transfusion, 38(8), 1998, pp. 722-728
LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC-LYMPHOCYTIC-LEUKEMIA (CLL) RECEIVING FLUDARABINE REGIMENS AS INITIAL THERAPY
Authors: KEATING MJ OBRIEN S LERNER S KOLLER C BERAN M ROBERTSON LE FREIREICH EJ ESTEY E KANTARJIAN H
Citation: Mj. Keating et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC-LYMPHOCYTIC-LEUKEMIA (CLL) RECEIVING FLUDARABINE REGIMENS AS INITIAL THERAPY, Blood, 92(4), 1998, pp. 1165-1171
PROTEASOME INHIBITORS INDUCE APOPTOSIS IN GLUCOCORTICOID-RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIC LYMPHOCYTES
Authors: CHANDRA J NIEMER I GILBREATH J KLICHE KO ANDREEFF M FREIREICH EJ KEATING M MCCONKEY DJ
Citation: J. Chandra et al., PROTEASOME INHIBITORS INDUCE APOPTOSIS IN GLUCOCORTICOID-RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIC LYMPHOCYTES, Blood, 92(11), 1998, pp. 4220-4229
THE FUTURE OF CLINICAL CANCER-RESEARCH IN THE NEXT MILLENNIUM
Authors: FREIREICH EJ
Citation: Ej. Freireich, THE FUTURE OF CLINICAL CANCER-RESEARCH IN THE NEXT MILLENNIUM, Clinical cancer research, 3(12), 1997, pp. 2563-2570
WHO TOOK THE CLINICAL OUT OF CLINICAL RESEARCH - MOUSE VERSUS MAN - 7TH DAVID-A.-KARNOFSKY-MEMORIAL-LECTURE-1976
Authors: FREIREICH EJ
Citation: Ej. Freireich, WHO TOOK THE CLINICAL OUT OF CLINICAL RESEARCH - MOUSE VERSUS MAN - 7TH DAVID-A.-KARNOFSKY-MEMORIAL-LECTURE-1976, Clinical cancer research, 3(12), 1997, pp. 2711-2722
CHRONIC MYELOGENOUS LEUKEMIA - PROGRESS AT THE M.-D.-ANDERSON-CANCER-CENTER OVER THE PAST 2 DECADES AND FUTURE-DIRECTIONS - FIRST FREIREICH,EMIL,J AWARD LECTURE
Authors: KANTARJIAN HM TALPAZ M OBRIEN S KURZROCK R GUTTERMAN J KEATING MJ MCCREDIE KB FREIREICH EJ
Citation: Hm. Kantarjian et al., CHRONIC MYELOGENOUS LEUKEMIA - PROGRESS AT THE M.-D.-ANDERSON-CANCER-CENTER OVER THE PAST 2 DECADES AND FUTURE-DIRECTIONS - FIRST FREIREICH,EMIL,J AWARD LECTURE, Clinical cancer research, 3(12), 1997, pp. 2723-2733
TREATMENT OF NEUTROPENIA-RELATED FUNGAL-INFECTIONS WITH GRANULOCYTE-COLONY-STIMULATING FACTOR-ELICITED WHITE BLOOD-CELL TRANSFUSIONS - A PILOT-STUDY
Authors: DIGNANI MC ANAISSIE EJ HESTER JP OBRIEN S VARTIVARIAN SE REX JH KANTARJIAN H JENDIROBA DB LICHTIGER B ANDERSSON BS FREIREICH EJ
Citation: Mc. Dignani et al., TREATMENT OF NEUTROPENIA-RELATED FUNGAL-INFECTIONS WITH GRANULOCYTE-COLONY-STIMULATING FACTOR-ELICITED WHITE BLOOD-CELL TRANSFUSIONS - A PILOT-STUDY, Leukemia, 11(10), 1997, pp. 1621-1630
THE ROAD TO THE CURE OF ACUTE LYMPHOBLASTIC-LEUKEMIA - A PERSONAL PERSPECTIVE
Authors: FREIREICH EJ
Citation: Ej. Freireich, THE ROAD TO THE CURE OF ACUTE LYMPHOBLASTIC-LEUKEMIA - A PERSONAL PERSPECTIVE, Oncology, 54(4), 1997, pp. 265-269
INTRODUCTION TO LEUKEMIA LONG-TERM SURVIVAL
Authors: FREIREICH EJ KEATING MJ
Citation: Ej. Freireich et Mj. Keating, INTRODUCTION TO LEUKEMIA LONG-TERM SURVIVAL, Cancer, 80(11), 1997, pp. 2175-2175
LONG-TERM FOLLOW-UP OF PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA TREATED AT THE UNIVERSITY-OF-TEXAS M.-D.-ANDERSON-CANCER-CENTER
Authors: ESTEY E DELIMA M STROM S PIERCE S FREIREICH EJ KEATING MJ
Citation: E. Estey et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA TREATED AT THE UNIVERSITY-OF-TEXAS M.-D.-ANDERSON-CANCER-CENTER, Cancer, 80(11), 1997, pp. 2176-2180
CONCLUSIONS REGARDING LEUKEMIA LONG-TERM SURVIVAL
Authors: FREIREICH EJ KEATING MJ
Citation: Ej. Freireich et Mj. Keating, CONCLUSIONS REGARDING LEUKEMIA LONG-TERM SURVIVAL, Cancer, 80(11), 1997, pp. 2215-2217
PROTEASE ACTIVATION IS REQUIRED FOR GLUCOCORTICOID-INDUCED APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIC LYMPHOCYTES
Authors: CHANDRA J GILBREATH J FREIREICH EJ KLICHE KO ANDREEFF M KEATING M MCCONKEY DJ
Citation: J. Chandra et al., PROTEASE ACTIVATION IS REQUIRED FOR GLUCOCORTICOID-INDUCED APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIC LYMPHOCYTES, Blood, 90(9), 1997, pp. 3673-3681
CYCLOPHOSPHAMIDE (CTX), ARA-C AND TOPOTECAN (TOP) (CAT) IN PATIENTS (PTS) WITH REFRACTORY OR RELAPSED ACUTE LEUKEMIAS AND TRANSFORMED CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: CORTES J KANTARJIAN H BERAN M OBRIEN S KOLLER C KORNBLAU S ANDREEFF M KEATING M FREIREICH EJ ESTEY E
Citation: J. Cortes et al., CYCLOPHOSPHAMIDE (CTX), ARA-C AND TOPOTECAN (TOP) (CAT) IN PATIENTS (PTS) WITH REFRACTORY OR RELAPSED ACUTE LEUKEMIAS AND TRANSFORMED CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 90(10), 1997, pp. 2251-2251
AMSACRINE AND CONTINUOUS-INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE AS INDUCTION THERAPY FOR PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA
Authors: GHADDAR HM PIERCE S KANTARJIAN HM FREIREICH EJ KEATING MJ ESTEY EH
Citation: Hm. Ghaddar et al., AMSACRINE AND CONTINUOUS-INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE AS INDUCTION THERAPY FOR PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA, Leukemia & lymphoma, 22(1-2), 1996, pp. 71-76
FACTORS PREDICTING COMPLETE REMISSION AND SUBSEQUENT DISEASE-FREE SURVIVAL AFTER A 2ND COURSE OF INDUCTION THERAPY IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RESISTANT TO THE FIRST
Authors: ANDERLINI P GHADDAR HM SMITH TL PIERCE S KANTARJIAN HM OBRIEN S KEATING MJ FREIREICH EJ ESTEY EH
Citation: P. Anderlini et al., FACTORS PREDICTING COMPLETE REMISSION AND SUBSEQUENT DISEASE-FREE SURVIVAL AFTER A 2ND COURSE OF INDUCTION THERAPY IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RESISTANT TO THE FIRST, Leukemia, 10(6), 1996, pp. 964-969
FAMILIAL MYELOID-LEUKEMIA ASSOCIATED WITH LOSS OF THE LONG ARM OF CHROMOSOME-5
Authors: OLOPADE OI ROULSTON D BAKER T NARVID S LEBEAU MM FREIREICH EJ LARSON RA GOLOMB HM
Citation: Oi. Olopade et al., FAMILIAL MYELOID-LEUKEMIA ASSOCIATED WITH LOSS OF THE LONG ARM OF CHROMOSOME-5, Leukemia, 10(4), 1996, pp. 669-674
PNEUMONIA DURING REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS WITH AML OR MDS
Authors: WILHELM M KANTARJIAN HM OBRIEN S PIERCE S KEATING MJ FREIREICH EJ ESTEY EH
Citation: M. Wilhelm et al., PNEUMONIA DURING REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS WITH AML OR MDS, Leukemia, 10(12), 1996, pp. 1870-1873
FLUORESCENCE VIDEOMICROSCOPY STUDY OF NEUTROPHIL ADHERENCE TO HPB-ALLT-CELL LINE - EVIDENCE OF DIRECT CELL-CELL INTERACTION UPON STIMULATION
Authors: JENDIROBA DB MCINTYRE BW WOODSIDE DG WOOTEN DK KEYHANI A LIU B PEARLMAN M PAGLIARO LC LICHTIGER B FREIREICH EJ
Citation: Db. Jendiroba et al., FLUORESCENCE VIDEOMICROSCOPY STUDY OF NEUTROPHIL ADHERENCE TO HPB-ALLT-CELL LINE - EVIDENCE OF DIRECT CELL-CELL INTERACTION UPON STIMULATION, Blood, 88(10), 1996, pp. 2850-2850
CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROMES (MDS) WITH ABNORMALITIES IN THE LONG ARM OF CHROMOSOME-3
Authors: CORTES J KEATING M OBRIEN S KANTARJIAN H FREIREICH EJ ESTEY E
Citation: J. Cortes et al., CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROMES (MDS) WITH ABNORMALITIES IN THE LONG ARM OF CHROMOSOME-3, Blood, 88(10), 1996, pp. 3340-3340
PROGNOSTIC-SIGNIFICANCE OF PROGENITOR-CELL DOUBLING TIME (P-2) IN AML
Authors: PAGLIARO LC DREW MC LIU B FREIREICH EJ
Citation: Lc. Pagliaro et al., PROGNOSTIC-SIGNIFICANCE OF PROGENITOR-CELL DOUBLING TIME (P-2) IN AML, Blood, 88(10), 1996, pp. 3361-3361
A COMPARISON OF THE SENSITIVITY OF INTERPHASE FISH ON BLOOD AND HYPERMETAPHASE FISH ON BONE-MARROW FOR THE PRESENCE OF THE PH CHROMOSOME INCML
Authors: SEONG D THALL P KANTARJIAN H TALPAZ M OBRIEN S SWANTKOWSKI J RIOS M XU JP SHEN Y ZIMMERMAN S GLASSMAN A RAMAGLI L ROBINSON J KEATING M FREIREICH EJ CHAMPLIN R SICILIANO MJ
Citation: D. Seong et al., A COMPARISON OF THE SENSITIVITY OF INTERPHASE FISH ON BLOOD AND HYPERMETAPHASE FISH ON BONE-MARROW FOR THE PRESENCE OF THE PH CHROMOSOME INCML, Blood, 88(10), 1996, pp. 3370-3370
DETECTION OF CLINICALLY RELEVANT MINIMAL RESIDUAL DISEASE IN ACUTE MYELOGENOUS LEUKEMIA BY HYPERMETAPHASE-FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: SEONG D ESTEY E CLAXTON D XU JP SWATKOWSKI J ZHAO Y OBRIEN S KEATING M FREIREICH EJ ANDREEF M KANTARJIAN H CHAMPLIN R SICILIANO MJ
Citation: D. Seong et al., DETECTION OF CLINICALLY RELEVANT MINIMAL RESIDUAL DISEASE IN ACUTE MYELOGENOUS LEUKEMIA BY HYPERMETAPHASE-FLUORESCENCE IN-SITU HYBRIDIZATION, Blood, 88(10), 1996, pp. 3371-3371
Risultati: 1-25 | 26-50 | 51-63